Autori: Ruzic Dusan
Naslov | The histone deacetylase inhibitor Scriptaid targets G-quadruplexes (Article) |
Autori | Sanchez Martin Victoria Ruzic Dusan ![]() ![]() |
Info | OPEN BIOLOGY, (2025), vol. 15 br. 2, str. - |
Projekat | Ministry of Science and Innovation of Spain (Instituto de Salud Carlos III (ISCIII) - European Union) [PI21/00497, PID2020-120481RB-I00/AEI/10.13039/501100011033]; local government Junta de Andalucia through PAIDI research groups [BIO-344]; Ministry of Science, Technological Development and Innovation of the Republic of Serbia (University of Belgrade-Faculty of Pharmacy) [451-03-65/2024-03/200161]; Government of Spain [FPU16/05822]; University of Almeria [CPRE2023-069] |
Ispravka | Web of Science Članak Elečas Rang časopisa |
|
Naslov | Pioneering first-in-class HDAC-ROCK inhibitors as potential multitarget anticancer agents (Article) |
Autori | Beljkas Milan Ruzic Dusan ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
Info | FUTURE MEDICINAL CHEMISTRY, (2025), vol. 17 br. 4, str. 393-407 |
Projekat | Ministry of Science, Technological Development and Innovation, Republic of Serbia; University of Belgrade-Faculty of Pharmacy [451- 03-65/2024-03/200161, 451-03-66/2024-03/200161]; Ministry of Science, Technological Development and Innovation, Republic of Serbia; University of Belgrade-Institute for Medical Research [451-03-66/2024-03/200015]; Ministry of Science, Technological Development and Innovation, Republic of Serbia; Institute for Oncology and Radiology of Serbia [451-03-66/2024-03/200043] |
Ispravka | Web of Science Članak Elečas Rang časopisa |
|
Naslov | Pioneering first-in-class HDAC-ROCK inhibitors as potential multitarget anticancer agents (Article; Early Access) |
Autori | Beljkas Milan Ruzic Dusan ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
Info | FUTURE MEDICINAL CHEMISTRY, (2025), vol. br. , str. - |
Projekat | Ministry of Science, Technological Development and Innovation, Republic of Serbia, through Grant Agreement with University of Belgrade-Faculty of Pharmacy [451- 03-65/2024-03/200161, 451-03-66/2024-03/200161]; Ministry of Science, Technological Development and Innovation, Republic of Serbia, through Grant Agreement with University of Belgrade-Institute for Medical Research [451-03-66/2024-03/200015]; Ministry of Science, Technological Development and Innovation, Republic of Serbia, through Grant Agreement with Institute for Oncology and Radiology of Serbia [451-03-66/2024-03/200043] |
Ispravka | Web of Science Članak Elečas Rang časopisa Citati: |
|
Naslov | Targeting noncoding RNAs to treat atherosclerosis (Review; Early Access) |
Autori | Sopic Miron D ![]() ![]() |
Info | BRITISH JOURNAL OF PHARMACOLOGY, (2024), vol. br. , str. - |
Projekat | British Heart Foundation [CA21153]; COST (European Cooperation in Science and Technology) |
Ispravka | Web of Science Članak Elečas Rang časopisa Citati: |
|
Naslov | Targeting Histone Deacetylases 6 in Dual-Target Therapy of Cancer (Review) |
Autori | Beljkas Milan Ilic Aleksandra ![]() ![]() ![]() ![]() ![]() ![]() |
Info | PHARMACEUTICS, (2023), vol. 15 br. 11, str. - |
Projekat | Ministry of Science, Technological Development and Innovation, Republic of Serbia |
Ispravka | Web of Science Članak Elečas Rang časopisa |
|
Naslov | Discovery of novel small molecule inhibitors of HDAC6 that suppress liver fibrosis (Meeting Abstract) |
Autori | Borrello Maria Teresa Ruzic Dusan ![]() ![]() |
Info | JOURNAL OF HEPATOLOGY, (2023), vol. 78 br. , Suppl. 1, str. S332-S332 |
Ispravka | Web of Science Elečas Rang časopisa |
|
Naslov | Correlating Basal Gene Expression across Chemical Sensitivity Data to Screen for Novel Synergistic Interactors of HDAC Inhibitors in Pancreatic Carcinoma (Article) |
Autori | Djokovic Nemanja ![]() ![]() ![]() ![]() ![]() |
Info | PHARMACEUTICALS, (2023), vol. 16 br. 2, str. - |
Projekat | Ministry of Science, Technological Development and Innovation, Republic of Serbia; University of Belgrade-Faculty of Pharmacy [451-03-47/2023-01/200161] |
Ispravka | Web of Science Članak Elečas Rang časopisa |
|
Naslov | Discovery of 1-Benzhydryl-Piperazine-Based HDAC Inhibitors with Anti-Breast Cancer Activity: Synthesis, Molecular Modeling, In Vitro and In Vivo Biological Evaluation (Article) |
Autori | Ruzic Dusan ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
Info | PHARMACEUTICS, (2022), vol. 14 br. 12, str. - |
Projekat | Ministry of Education, Science and Technological Development, Republic of Serbia with University of Belgrade-Faculty of Pharmacy [451-03-68/2022-14/200161]; Ministry of Education, Science, and the Technological Development of the Republic of Serbia [ON171017] |
Ispravka | Web of Science Članak Elečas Rang časopisa Citati: Web of Science |
|
Naslov | Dual LSD1 and HDAC6 Inhibition Induces Doxorubicin Sensitivity in Acute Myeloid Leukemia Cells (Article) |
Autori | Bulut Ipek Lee Adam Cevatemre Buse Ruzic Dusan ![]() ![]() |
Info | CANCERS, (2022), vol. 14 br. 23, str. - |
Projekat | Koc University School of Medicine (KU-SOM budget) [255021011]; Koc University Research Center for Translational Medicine (KUTTAM); Turkish Ministry of Health (TUSEB) [4012]; UKRI Biotechnology and Biological Sciences Research Council, Norwich Research Park, Biosciences Doctoral Training Partnership [BB/M011216/1]; Ministry of Education, Science and Technological Development, Republic of Serbia [451-03-9/2021-14/200161]; Cancer Research UK [C8717/A18245]; European Research Council (ERC) under the European Union [679479]; EU COSTAction CM1406 Epigenetic Chemical Biology |
Ispravka | Web of Science Članak Elečas Rang časopisa Citati: Web of Science |
|
Naslov | Design of Dual COX-2 and 5-LOX Inhibitors with Iron-Chelating Properties Using Structure-Based and Ligand-Based Methods (Article) |
Autori | Boskovic Jelena Ruzic Dusan ![]() ![]() ![]() ![]() |
Info | LETTERS IN DRUG DESIGN & DISCOVERY, (2022), vol. 19 br. 4, str. 279-292 |
Projekat | Ministry of Education, Science and Technological Development, Republic of Serbia; University of Belgrade-Faculty of Pharmacy [451-03-9/2021-14/200161] |
Ispravka | Web of Science Članak Elečas Rang časopisa Citati: Web of Science Scopus |
|